ENESTg1_2B: ENESTg1, figure 2B
In raredd/kmdata: A Database of Reconstructed Individual Patient Level Data from Oncology Clinical Trials
ENESTg1_2B R Documentation
ENESTg1, figure 2B
Description
Kaplan-Meier digitized data from ENESTg1, figure 2B (PMID 25882987). A reported sample size of 647 for a primary endpoint of PFS in colorectal cancer.
Usage
ENESTg1_2B
Format
A data frame of 644 observations and 3 variables:
time event time (in months)
event OS event indicator (0: no event, 1: event)
arm treatment arms (imatinib, nilotinib)
Source
Blay J-Y, Shen L, Kang Y-K, et al. Nilotinib versus imatinib as
first-line therapy for patients with unresectable or metastatic
gastrointestinal stromal tumours (ENESTg1): a randomised phase 3
trial. Lancet Oncol 2015; 16: 550–60.
Examples
summary(ENESTg1_2B)
kmplot(ENESTg1_2B)
raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
| ENESTg1_2B | R Documentation |
ENESTg1, figure 2B
Description
Kaplan-Meier digitized data from ENESTg1, figure 2B (PMID 25882987). A reported sample size of 647 for a primary endpoint of PFS in colorectal cancer.
Usage
ENESTg1_2B
Format
A data frame of 644 observations and 3 variables:
time | event time (in months) | |
event | OS event indicator (0: no event, 1: event) |
|
arm | treatment arms (imatinib, nilotinib) | |
Source
Blay J-Y, Shen L, Kang Y-K, et al. Nilotinib versus imatinib as first-line therapy for patients with unresectable or metastatic gastrointestinal stromal tumours (ENESTg1): a randomised phase 3 trial. Lancet Oncol 2015; 16: 550–60.
Examples
summary(ENESTg1_2B)
kmplot(ENESTg1_2B)
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
Embedding an R snippet on your website
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.